IRIDEX Stock
IRIDEX Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Patrick Mercer
- Employees
- 93
- Market cap
- $14 M
- IPO
- 16/02/1996
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each…
IRIDEX stock: price history
1D
-1.2%
1W
-8.5%
1M
+34.2%
6M
-23.2%
YTD
-28.5%
1Y
-22.4%
2Y
-48.8%
5Y
-89.0%
10Y
-93.6%
Next earnings date
Next earnings date
17/11/2026 (in 31 days)
Volatility around earnings
~52% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about IRIDEX
Analyst assessment of IRIDEX
PRICE TARGET LOW
US$2.75
CONSENSUS
US$2.75
MEDIAN
US$2.75
PRICE TARGET HIGH
US$2.75
0
STRONG BUY
3
BUY
1
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 15/05/2024
IRIDEX stock metrics
P/E
-4
P/B
3.89
EV/EBITDA
-8
RETURN ON EQUITY
-34.8%
NET MARGIN
-10.1%
DEBT/EQUITY
1.1
DIVIDEND YIELD
0.0%
AS OF
04/07/2026
Free float & liquidity
FREE FLOAT
61.2%
FLOAT SHARES
10,742,201
AVG. DAILY VOLUME (30D)
753,187
Insider transactions (SEC)
Novel Inspiration International Co., Ltd.
Lin Shih-Yao David
Lin Shih-Yao David
Lin Shih-Yao David
Lin Shih-Yao David
Institutional holders
Comparable stocks
Frequently asked questions about IRIDEX stock
What does IRIDEX do?
IRIDEX Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Patrick Mercer, the company employs around 93 people.
The IPO was on 16/02/1996; the stock trades on NASDAQ under the ticker IRIX.
What do analysts say about IRIDEX stock?
4 analysts rate the stock, the consensus is Buy (as of 15/05/2024).
The average price target is US$2.75, ranging from US$2.75 to US$2.75, with a median of US$2.75.
This is an external assessment, not a statement by Market Jury.
When does IRIDEX report next?
The next earnings date is 17/11/2026.
Around past earnings, price swings were roughly 52% stronger than usual.
Does IRIDEX pay a dividend?
No, IRIDEX currently does not pay a dividend.
Which stocks are comparable to IRIDEX?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get IRIDEX stock analyzed?
Clicking "Analyze stock" lets five strategies assess IRIDEX against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.